NEW YORK (TheStreet) -- Earlier this week German pharmaceutical company Bayer (BAYRY) upped its bid to acquire agricultural products supplier Monsanto  (MON) , and now it appears that a deal could be announced as early as next week, BloombergTV's Mark Barton reported on "Bloomberg Markets" Friday morning.

A combination of the two companies would create the largest maker of seeds and pesticides in the world.

Monsanto is said to be pushing for a price closer to $130 per share, Barton said. The two companies are also said to be discussing increasing the $1.5 billion breakup fee as well.

"The deal could squeeze farmers amid weak crop prices as well," Barton concluded.

Shares of Monsanto are lower in late Friday morning trading.

Separately, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. TheStreet Ratings has this to say about the recommendation:

We rate MONSANTO CO as a Buy with a ratings score of B. This is driven by some important positives, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share.

You can view the full analysis from the report here: MON